[Effect of L-dopa and propranolol administration on GH secretion in essential obesity in women].
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D005260:Female; D013006:Growth Hormone / Q000378:metabolism*; D006801:Humans; D007275:Injections, Intravenous; D007980:Levodopa; D008297:Male; D008875:Middle Aged; D009765:Obesity / Q000503:physiopathology*; D010902:Pituitary Gland / Q000503:physiopathology*; D010903:Pituitary Gland, Anterior / Q000503:physiopathology*; D011433:Propranolol; D013268:Stimulation, Chemical
D007980:Levodopa; D013006:Growth Hormone; D011433:Propranolol
Efecto de la administración de L-dopa y propranolol sobre la secreción de GH en la obesidad esencial de la mujer